Cohen syndrome is associated with major glycosylation defects
Синдром Коэна связан с выраженными нарушениями гликозилирования
2013-12-13
SCID: 54.1/y89g4zq5
Discuss with AI
Cohen syndromeGolgi integrityVPS13B deficiencyendosomal-lysosomal traffickingglycosylation defects
Figures from the paper
Abstract (AI)
Cohen syndrome (CS) is a rare autosomal recessive disorder with multisytemic clinical features due to mutations in the VPS13B gene, which has recently been described encoding a mandatory membrane protein involved in Golgi integrity. As the Golgi complex is the place where glycosylation of newly synthesized proteins occurs, we hypothesized that VPS13B deficiency, responsible of Golgi apparatus disturbance, could lead to glycosylation defects and/or mysfunction of this organelle, and thus be a cause of the main clinical manifestations of CS. The glycosylation status of CS serum proteins showed a very unusual pattern of glycosylation characterized by a significant accumulation of agalactosylated fucosylated structures as well as asialylated fucosylated structures demonstrating a major defect of glycan maturation in CS. However, CS transferrin and α1-AT profiles, two liver-derived proteins, were normal. We also showed that intercellular cell adhesion molecule 1 and LAMP-2, two highly glycosylated cellular proteins, presented an altered migration profile on SDS-PAGE in peripheral blood mononuclear cells from CS patients. RNA interference against VPS13B confirmed these glycosylation defects. Experiments with Brefeldin A demonstrated that intracellular retrograde cell trafficking was normal in CS fibroblasts. Furthermore, early endosomes were almost absent in these cells and lysosomes were abnormally enlarged, suggesting a crucial role of VPS13B in endosomal-lysosomal trafficking. Our work provides evidence that CS is associated to a tissue-specific major defect of glycosylation and endosomal-lysosomal trafficking defect, suggesting that this could be a new key element to decipher the mechanisms of CS physiopathology.
Key Findings
1
Cohen syndrome fibroblasts exhibit nearly absent early endosomes and enlarged lysosomes, indicating defective endosomal-lysosomal trafficking despite normal intracellular retrograde trafficking.
2
Cohen syndrome serum proteins display major glycan-maturation defects, with accumulation of agalactosylated and asialylated fucosylated structures.
3
Glycosylation abnormalities are tissue-specific: liver-derived transferrin and α1-antitrypsin profiles remain normal in Cohen syndrome.
4
ICAM-1 and LAMP-2 show altered SDS-PAGE migration in patient peripheral blood mononuclear cells, consistent with abnormal glycosylation.
5
VPS13B RNA interference reproduces the observed glycosylation defects, supporting a direct role for VPS13B deficiency.
Research Object
Cohen syndrome cells and serum proteins associated with VPS13B deficiency
Research Subject
Tissue-specific glycan maturation defects and endosomal–lysosomal trafficking abnormalities
Publication Details
Publication Date
2013-12-13
Journal
Publisher
ISSN
Cited by
110
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai1
Cited by5
Cohen Syndrome: Review of the Literature2018
Periodontal disorders in a cohort of patients with Cohen syndrome2020
COHEN SYNDROME2020
Generation of Three iPSC Lines from Fibroblasts of a Patient with Cohen Syndrome2024
Novel VPS13B Mutations in Three Large Pakistani Cohen Syndrome Families Suggests a Baloch Variant with Autistic-Like Features2015